INSYS Therapeutics to Present at J.P. Morgan Healthcare Conference

On January 3, 2018 INSYS Therapeutics, Inc. (NASDAQ:INSY), reported that Saeed Motahari, president and chief executive officer, and Andrew Long, chief financial officer, will present at the 36th annual J.P. Morgan Healthcare Conference as follows(Press release, Insys Therapeutics, JAN 3, 2018, View Source;p=RssLanding&cat=news&id=2324652 [SID1234522833]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Date: Thursday, Jan. 11, 2018
Time: 7:30 a.m. Pacific Standard Time
Location: San Francisco – Westin St. Francis Hotel
The presentation will be webcast live at the aforementioned time, and archived for 30 days thereafter, via the Investors section of company’s website at View Source, under Presentations & Events. The presentation slides will be available during the conference, accessible at the same webpage.

In addition to making a presentation, management will also provide an overview of the company’s business in one-on-one meetings with investors who are registered to attend the conference.